Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
ASTC 
Astrotech Corp (ASTC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/11/2025: ASTC (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
0 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
Analysis of Past Performance
Type Stock | Historic Profit -19.92% | Avg. Invested days 37 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 07/11/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 9.64M USD | Price to earnings Ratio - | 1Y Target Price 25 |
Price to earnings Ratio - | 1Y Target Price 25 | ||
Volume (30-day avg) - | Beta 0.24 | 52 Weeks Range 5.39 - 12.29 | Updated Date 06/29/2025 |
52 Weeks Range 5.39 - 12.29 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -8.35 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -724.16% |
Management Effectiveness
Return on Assets (TTM) -27.99% | Return on Equity (TTM) -44.54% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value -11109408 | Price to Sales(TTM) 10.67 |
Enterprise Value -11109408 | Price to Sales(TTM) 10.67 | ||
Enterprise Value to Revenue 49.38 | Enterprise Value to EBITDA 1.79 | Shares Outstanding 1693950 | Shares Floating 1158844 |
Shares Outstanding 1693950 | Shares Floating 1158844 | ||
Percent Insiders 16.91 | Percent Institutions 22.89 |
Upturn AI SWOT
Astrotech Corp
Company Overview
History and Background
Astrotech Corp. was founded in 1984 and has evolved from a space technology company to one focusing on commercializing technology derived from space research. It has faced financial difficulties and restructured operations over the years.
Core Business Areas
- Astrotech Technologies: Focuses on commercializing advanced technology including mass spectrometry devices for various applications.
Leadership and Structure
Astrotech's leadership consists of its CEO and a board of directors. The organizational structure is streamlined, reflecting its smaller size and focus.
Top Products and Market Share
Key Offerings
- AgLAB: A mass spectrometer for agricultural applications, designed to rapidly detect pathogens and other contaminants in food and water. Market share data unavailable. Competitors include Thermo Fisher Scientific (TMO) and Agilent Technologies (A).
- BreathTech: A potential breath analysis device for medical diagnostics. Early stage of development, no market share data available. Competitors include Owlstone Medical (Private) and Metabolon (Private).
Market Dynamics
Industry Overview
Astrotech operates in the analytical instrumentation market, specifically mass spectrometry and related fields. This market is driven by increasing demand for advanced testing and analysis in various sectors.
Positioning
Astrotech is a niche player focusing on specific applications for its core technology. Its competitive advantage lies in its proprietary technology and potential for unique solutions. The risk is that the company is thinly capitalized and relies heavily on grants, and strategic capital.
Total Addressable Market (TAM)
The TAM for mass spectrometry and related analytical instrumentation is estimated to be several billion dollars. Astrotech is targeting specific segments within this market, with the goal to secure a small percentage of the TAM, making it worth potentially hundreds of millions of dollars.
Upturn SWOT Analysis
Strengths
- Proprietary technology in mass spectrometry
- Potential for unique solutions in niche markets
- Experienced management team
Weaknesses
- Limited financial resources
- Dependence on grants and contracts
- Small market capitalization
- History of losses
- Volatility in stock price
Opportunities
- Growing demand for advanced analytical instrumentation
- Potential partnerships with larger companies
- Expansion into new markets
- Securing additional government grants
Threats
- Competition from larger, well-established companies
- Technological obsolescence
- Economic downturns
- Regulatory changes
Competitors and Market Share
Key Competitors
- TMO
- ABT
- ILMN
Competitive Landscape
Astrotech faces significant competition from larger, well-funded companies in the analytical instrumentation market. Its ability to compete depends on its proprietary technology and niche market focus.
Growth Trajectory and Initiatives
Historical Growth: Astrotech's historical growth has been limited and inconsistent, due to financial challenges and market conditions.
Future Projections: Future growth projections are uncertain and dependent on the company's ability to commercialize its technology and secure funding.
Recent Initiatives: Recent initiatives include focusing on agricultural and medical applications for its mass spectrometry technology and pursuing strategic partnerships.
Summary
Astrotech Corp is a small company with promising technology facing considerable financial hurdles. Its ability to secure funding and successfully commercialize its technology will determine its future. The company needs to focus on strategic partnerships and market expansion to survive and thrive. Investors should watch out for further dilution of stock and cash burn rate.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Market research reports
- Analyst estimates
Disclaimers:
This analysis is based on publicly available information and is not financial advice. Investment decisions should be made based on individual circumstances and consultation with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Astrotech Corp
Exchange NASDAQ | Headquaters Austin, TX, United States | ||
IPO Launch date 1995-12-20 | CEO, CTO & Chairman Mr. Thomas Boone Pickens III | ||
Sector Technology | Industry Scientific & Technical Instruments | Full time employees 30 | Website https://www.astrotechcorp.com |
Full time employees 30 | Website https://www.astrotechcorp.com | ||
Astrotech Corporation operates as a mass spectrometry company worldwide. It owns and licenses the intellectual property related to the Astrotech Mass Spectrometer Technology, a platform mass spectrometry technology. The company also develops TRACER 1000, a mass spectrometer-based explosive trace detector to replace the explosives trace detectors used at airports, cargo and other secured facilities, and borders. In addition, it develops AGLAB-1000, a mass spectrometer for use in the hemp and cannabis market. Further, the company develops BreathTest-1000, a breath analysis tool to screen for volatile organic compound metabolites found in a person's breath; and Pro-Control 1000-D2, a mass spectrometer. The company was formerly known as SPACEHAB, Inc. and changed its name to Astrotech Corporation in 2009. The company was incorporated in 1984 and is based in Austin, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.